Discover the full record of transactions filed by Zinda Michael, Directeur Scientifique. Officer active across 1 companies, notably Repare Therapeutics Inc.. In total, 9 filings have been logged. Total volume traded: €1.6m. The latest transaction was filed on 15 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Michael Zinda is Executive Vice President and Chief Science Officer at Repare Therapeutics Inc. He is responsible for leading the company's research and development efforts, focusing on scientific innovation and the discovery of new treatments. Michael Zinda plays a crucial role in the strategic direction of research projects and in establishing scientific partnerships.